A couple of my former high school students and their family were visiting our congregation the last weekend in April for our annual Bible Conference. They had heard of my cancer, so after one of the Saturday services, she (SS) told my wife (Ruby, in case you didn’t know) about an antiparasitic that shows promise as a cancer treatment.
I work for a New York small business that provides email services and Web work services for those who do not have Internet access. Well, the following Wednesday, I saw a project in our work queue that I took on since it was about cancer. The customer wanted information on the Joe Tippens protocol for cancer and he wanted to know about buying the Merck brand of fenbendazole. It wasn’t hard to find the info for him (and it only cost him $18). When I told Ruby the drug name, she reminded me excitedly that it was the same stuff SS had told her about. (I had forgotten the name fenbendazole already.)
At least four of my acquaintances across the country are MDs. The next day (May 4, you should know) I finally remembered to ask one of them a question I’d been wanting to ask a real doctor for a few weeks: “What do you think of ivermectin as a cancer treatment?” He replied that ivermectin is good but he likes fenbendazole better. I hadn’t ever mentioned fenbendazole to him! (I should ask my other MD acquaintances the question now!)
So there you are. In the space of…what…five days, three different people from three different parts of the country brought fenbendazole to my attention. And none of them know each other. Coincidental? Perhaps. But I prefer to think otherwise.
OK, one more event. On May 19 I got an unexpected email from a nice, gray-haired grandma. Read it all